James Fox Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Fox.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Fox. James Fox is Director in Aviragen Therapeutics, Inc. ($NABI) and Director in GenMark Diagnostics, Inc. ($GNMK).
Latest Insider Trading Transactions of James Fox
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | Fox James | Director | Sell | U | 24.05 | 81,085 | 1,950,094 | 0 | 81.1 K to 0 (-100.00 %) |
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | Fox James | Director | Sell | U | 24.05 | 182,017 | 4,377,509 | 0 | 182 K to 0 (-100.00 %) |
| Feb 19 2021 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 7,355 | 0 | 182,017 | 174.7 K to 182 K (+4.21 %) |
| Jun 02 2020 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 13,066 | 0 | 174,662 | 161.6 K to 174.7 K (+8.09 %) |
| Mar 10 2020 | GNMK | GenMark Diagnostic ... | Fox James | Director | Buy | P | 5.50 | 9,000 | 49,500 | 81,085 | 72.1 K to 81.1 K (+12.49 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 25,889 | 0 | 161,596 | 135.7 K to 161.6 K (+19.08 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 24,625 | 0 | 135,707 | 111.1 K to 135.7 K (+22.17 %) |
| May 30 2017 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,183 | 0 | 111,082 | 100.9 K to 111.1 K (+10.09 %) |
| May 31 2016 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 14,161 | 0 | 100,899 | 86.7 K to 100.9 K (+16.33 %) |
| Nov 02 2015 | GNMK | GenMark Diagnostic ... | Fox James | Director | Buy | P | 6.90 | 12,000 | 82,800 | 72,085 | 60.1 K to 72.1 K (+19.97 %) |
| Aug 13 2015 | NABI | Aviragen Therapeut ... | Fox James | Director | Grant | A | 2.49 | 2,500 | 6,225 | 2,500 | 0 to 2.5 K |
| Jun 11 2015 | NABI | Aviragen Therapeut ... | Fox James | Director | Buy | P | 1.99 | 70,000 | 139,300 | 100,614 | 30.6 K to 100.6 K (+228.65 %) |
| Jun 01 2015 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,806 | 0 | 86,738 | 75.9 K to 86.7 K (+14.23 %) |
| May 14 2015 | NABI | Aviragen Therapeut ... | Fox James | Director | Grant | A | 2.20 | 7,500 | 16,500 | 7,500 | 0 to 7.5 K |
| Aug 11 2014 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 2,432 | 0 | 75,932 | 73.5 K to 75.9 K (+3.31 %) |
| Jun 02 2014 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 6,345 | 0 | 73,500 | 67.2 K to 73.5 K (+9.45 %) |
| May 23 2013 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 5,089 | 0 | 67,155 | 62.1 K to 67.2 K (+8.20 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | Fox James | Director | Buy | P | 4.20 | 23,810 | 100,002 | 23,810 | 0 to 23.8 K |
| Jun 08 2012 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,112 | 0 | 62,066 | 52 K to 62.1 K (+19.46 %) |
| Sep 03 2010 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,922 | 0 | 51,954 | 41 K to 52 K (+26.62 %) |
| Sep 03 2010 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 41,032 | 0 | 41,032 | 0 to 41 K |
Page: 1